This concept links ACE2 loss or degradation to amplified inflammatory signaling and more severe COVID-19 outcomes.
First-pass extracted concept
ACE2 degradation hypothesis of COVID-19 severity
Extracted Explainers
What the tool is doing
What problem it solves
Evidence Snippets
Here we propose that ACE2 contributes essentially to reverse this inflammatory state ... and that failure to do this, possibly induced by the degradation of ACE2 by SARS-COV-2, may underlie both severe CoViD-19 infection and its many post-infection manifestations, including the multi-inflammatory syndrome of children (MIS-C).
Supporting Sources
Linked Claims
ACE2 level is not monotonically related to age, but instead reaches a maximum at a young age and then decreases in a cell-type-dependent manner.
Failure of ACE2 to reverse the pro-inflammatory angiotensin-bradykinin state, possibly induced by SARS-CoV-2-mediated ACE2 degradation, may underlie severe COVID-19 and post-infection manifestations including MIS-C.
Age-associated increase in TACE/ADAM17 is proposed to drive ACE2 shedding from the cell membrane to serum, causing ACE2 cell protein to decline earlier and more steeply than ACE2 mRNA.
Higher viral receptor abundance does not necessarily favor virus propagation and can even slow it down according to a mathematical model discussed by the authors.